Publications
Export 122 results:
Filters: Author is J-P Julien [Clear All Filters]
, “Peripherin is a subunit of peripheral nerve neurofilaments: implications for differential vulnerability of CNS and peripheral nervous system axons.”, J Neurosci, vol. 32, no. 25, pp. 8501-8, 2012.
, “ALS pathogenesis: recent insights from genetics and mouse models.”, Prog Neuropsychopharmacol Biol Psychiatry, vol. 35, no. 2, pp. 363-9, 2011.
, “Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB-mediated pathogenic pathways.”, J Exp Med, vol. 208, no. 12, pp. 2429-47, 2011.
, “Gigaxonin mutation analysis in patients with NIFID.”, Neurobiol Aging, vol. 32, no. 8, pp. 1528-9, 2011.
, “Misfolded SOD1 associated with motor neuron mitochondria alters mitochondrial shape and distribution prior to clinical onset.”, PLoS One, vol. 6, no. 7, p. e22031, 2011.
, “The myosin Va head domain binds to the neurofilament-L rod and modulates endoplasmic reticulum (ER) content and distribution within axons.”, PLoS One, vol. 6, no. 2, p. e17087, 2011.
, “Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.”, Brain, vol. 134, no. Pt 9, pp. 2610-26, 2011.
, “Sensorimotor and cognitive function of a NEFL(P22S) mutant model of Charcot-Marie-Tooth disease type 2E.”, Behav Brain Res, vol. 219, no. 2, pp. 175-80, 2011.
, “Extracellular mutant SOD1 induces microglial-mediated motoneuron injury.”, Glia, vol. 58, no. 2, pp. 231-43, 2010.
, “Induction of protective immunity by vaccination with wild-type apo superoxide dismutase 1 in mutant SOD1 transgenic mice.”, J Neuropathol Exp Neurol, vol. 69, no. 10, pp. 1044-56, 2010.
, “Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS.”, J Neurochem, vol. 113, no. 5, pp. 1188-99, 2010.
, “Neuronal over-expression of chromogranin A accelerates disease onset in a mouse model of ALS.”, J Neurochem, vol. 115, no. 5, pp. 1102-11, 2010.
, “Reversal of neuropathy phenotypes in conditional mouse model of Charcot-Marie-Tooth disease type 2E.”, Hum Mol Genet, vol. 19, no. 13, pp. 2616-29, 2010.
, “Type III intermediate filament peripherin inhibits neuritogenesis in type II spiral ganglion neurons in vitro.”, Neurosci Lett, vol. 478, no. 2, pp. 51-5, 2010.
, “Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS.”, Nat Neurosci, vol. 13, no. 11, pp. 1396-403, 2010.
, “Wild-type human SOD1 overexpression does not accelerate motor neuron disease in mice expressing murine Sod1 G86R.”, Neurobiol Dis, vol. 40, no. 1, pp. 245-50, 2010.
, “Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis.”, Proc Natl Acad Sci U S A, vol. 106, no. 51, pp. 21777-82, 2009.
, “Macrophage colony stimulating factor (M-CSF) exacerbates ALS disease in a mouse model through altered responses of microglia expressing mutant superoxide dismutase.”, Exp Neurol, vol. 220, no. 2, pp. 267-75, 2009.
, “Real-time imaging reveals defects of fast axonal transport induced by disorganization of intermediate filaments.”, FASEB J, vol. 23, no. 9, pp. 3213-25, 2009.
, “Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase.”, J Neurosci, vol. 28, no. 41, pp. 10234-44, 2008.
, “Als2 mRNA splicing variants detected in KO mice rescue severe motor dysfunction phenotype in Als2 knock-down zebrafish.”, Hum Mol Genet, vol. 17, no. 17, pp. 2691-702, 2008.
, “[Dysfunction of axonal transport in neuropathies and motor neuron diseases].”, Med Sci (Paris), vol. 24, no. 1, pp. 65-71, 2008.
, “The endoplasmic reticulum-Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS.”, FASEB J, vol. 22, no. 7, pp. 2476-87, 2008.
, “Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1.”, J Neurochem, vol. 107, no. 1, pp. 253-64, 2008.
, “Requirement of myeloid cells for axon regeneration.”, J Neurosci, vol. 28, no. 38, pp. 9363-76, 2008.
